Viewing data from:

AZTREONAM

ANDA

AZTREONAM | A207069 | HIKMA PHARMACEUTICALS USA INC

2 strengths0 unique patents0 unique exclusivities

API Supply Chain10 active DMFs3 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

CURIA ITALY SRLAZTREONAM HYDRATED NON-STERILE ALPHA-FORM

DMF 171842004

TAPI NL BVAZTREONAM USP

DMF 193422006

CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTDAZTREONAM

DMF 268562013

GUANG'AN KINGDAY PHARMA AND CHEM CO LTDAZTREONAM USP

DMF 275082013

CURIA ITALY SRLAZTREONAM BETA FORM

DMF 337312019

CURIA ITALY SRLAZTREONAM ALFA FORM

DMF 337622019

CURIA FRANCE SASAZTREONAM BETA FORM

DMF 380552023

APITORIA PHARMA PRIVATE LTDAZTREONAM USP

DMF 386492023

CURIA FRANCE SASAZTREONAM ALFA FORM

DMF 397312024

FRESENIUS KABI IPSUM SRLAZTREONAM NON STERILE ALPHA

DMF 408412025

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveAZTREONAM

DMF 167512003

ORCHID CHEMICALS AND PHARMACEUTICALS LTDInactiveAZTREONAM

DMF 200142006

CHONGQING FUAN PHARMACEUTICAL CO LTDInactiveAZTREONAM USP (NON-STERILE BULK DRUG SUBSTANCE)

DMF 239712010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 1GM/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Feb 5, 2026

No patent or exclusivity listings for this strength.

#002 — 2GM/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Feb 5, 2026